What a Year…
Without a doubt, 2020 was a very peculiar year. I think nobody would have dreamt at the beginning of the year what was really coming our way. A pandemic of this magnitude, with these effects
Continue reading
Year: 2020
News from ECTRIMS 2020 – Biomarker – Neurofilament light (Nfl)
Disease-related biomarkers provide information about whether a disease is imminent, whether the disease already exists or how a disease will likely develop in individual cases. For many years, multiple sclerosis research has therefore been looking
Continue reading
News from ECTRIMS 2020 – The Prodromal MS – Does it exist?
How and when does multiple sclerosis begin? Does the disease begin with the first relapse or is this first relapse preceded by a so-called prodromal phase, during which the disease already exists, but does not
Continue reading
News from ECTRIMS – Disease Progression – PIRA (Progression Independent of Relapse Activity)
In clinical MS studies, disease progression is usually measured by the increase in the EDSS score. Now an increase in the EDSS score can occur as a result of a clinical relapse. Take, for example,
Continue reading
News from ECTRIMS 2020 – Obesity as a Risk Factor
The annual meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) took place from September 11th to 13th, 2020 and on September 26th, 2020 – completely virtual for the first time
Continue reading
News from ECTRIMS 2020 – MS Management in Times of COVID19
On the last day of the virtual ECTRIMS meeting, a full session was dedicated to the current developments in MS and COVID19. The updates from case-control studies carried out around the globe on the outcome
Continue reading
Vaccinations and Immunotherapy for MS
There are now a large number of different MS therapies. When choosing a therapy, it also plays a certain role whether and against which pathogens should be vaccinated. Especially in anticipation of a COVID19 vaccination,
Continue readingVaccination and MS
Infectious diseases can trigger an autoimmune reaction through the mechanism of so-called “molecular mimicry”. Due to structural similarities between the surface molecules of a pathogen and protein components in the central or peripheral nervous system,
Continue reading
Vaccine Safety
Vaccines undergo extremely careful clinical trials. This is reasonable, as there is a low risk tolerance for vaccines, since healthy adults or healthy children are usually vaccinated. Accordingly, it is more than irresponsible, as has
Continue reading General Information about Vaccination
In 1796, the British country doctor Edward Jenner conducted a daring experiment: Based on the observation that milkmaids who had been infected with cowpox (a mild cattle disease in humans, also known as milker’s nodules)
Continue reading
